UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
TNFR2-expressing CD4+ Foxp3+ regulatory T cells in cancer immunology and immunotherapy Journal article
Progress in Molecular Biology and Translational Science, 2019
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite  |  View/Download:7/0  |  Submit date:2019/05/08
Regulatory t Cells  Immunotherapy  Cancer  Tumor Necrosis Factor Receptor Type 2  Tumor Necrosis Factor  
The chromatin accessibility landscape of primary human cancers Journal article
Science, 2018,Volume: 362,Issue: 6413
Authors:  Corces M.R.;  Granja J.M.;  Shams S.;  Louie B.H.;  Seoane J.A.;  Zhou W.;  Silva T.C.;  Groeneveld C.;  Wong C.K.;  Cho S.W.;  Satpathy A.T.;  Mumbach M.R.;  Hoadley K.A.;  Robertson A.G.;  Sheffield N.C.;  Felau I.;  Castro M.A.A.;  Berman B.P.;  Staudt L.M.;  Zenklusen J.C.;  Laird P.W.;  Curtis C.;  Greenleaf W.J.;  Chang H.Y.
Favorite  |  View/Download:4/0  |  Submit date:2019/01/16
Osthole inhibited TGF beta-induced epithelial-mesenchymal transition (EMT) by suppressing NF-kappa B mediated Snail activation in lung cancer A549 cells Journal article
CELL ADHESION & MIGRATION, 2017,Volume: 11,Issue: 5-6,Page: 464-475
Authors:  Feng, Haitao;  Lu, Jin-Jian;  Wang, Yitao;  Pei, Lixia;  Chen, Xiuping
View  |  Adobe PDF(1506Kb)  |  Favorite  |  View/Download:64/6  |  Submit date:2018/10/30
Emt  Nf-kappa b  Osthole Snail  Tgf-beta 1  
TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis Journal article
Oncotarget, 2016,Volume: 7,Issue: 41,Page: 67196
Authors:  Zhou X.;  Mao Y.;  Zhu J.;  Meng F.;  Chen Q.;  Tao L.;  Li R.;  Fu F.;  Liu C.;  Hu Y.;  Wang W.;  Zhang H.;  Hua D.;  Chen W.;  Zhang X.
Favorite  |  View/Download:2/0  |  Submit date:2018/10/30
Co-inhibitor  Colorectal cancer  MicroRNA  TGF-β1  Tumor evasion  
Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients Journal article
Cancer Immunology, Immunotherapy, 2015,Volume: 64,Issue: 11,Page: 1475-1485
Authors:  Yan F.;  Du R.;  Wei F.;  Zhao H.;  Yu J.;  Wang C.;  Zhan Z.;  Ding T.;  Ren X.;  Chen X.;  Li H.
Favorite  |  View/Download:11/0  |  Submit date:2018/11/06
cd4+foxp3+ Regulatory t Cells  Clinical Pathology  Immunosuppression  Lung Cancer  Tumor Necrosis Factor Receptor Type Ii (Tnfr2)  
Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+ CD25+ FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells Journal article
JOURNAL OF IMMUNOLOGY, 2008,Volume: 180,Issue: 10,Page: 6467-6471
Authors:  Xin Chen;  Jeffrey J. Subleski;  Heather Kopf;  O.M. Zack Howard;  Daniela N. Männel;  Joost J. Oppenheim
Favorite  |  View/Download:2/0  |  Submit date:2019/01/14
t Cell  Cytokine Receptor  Tolerance/suppression/anergy  
Cutting Edge: Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: Applicability to tumor-infiltrating T regulatory cells Journal article
Journal of Immunology, 2008,Volume: 180,Issue: 10,Page: 6467-6471
Authors:  Chen X.;  Subleski J.J.;  Kopf H.;  Zack Howard O.M.;  Mannel D.N.;  Oppenheim J.J.
Favorite  |  View/Download:11/0  |  Submit date:2018/11/06